trending Market Intelligence /marketintelligence/en/news-insights/trending/nITL2oocsIN_hvDNAt6YNg2 content esgSubNav
In This List

Repro Med to begin trading on Nasdaq

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Repro Med to begin trading on Nasdaq

Repro Med Systems Inc.'s common shares will begin trading on the Nasdaq Capital Market under the ticker symbol REPR on Oct. 17.

Shares of the Chester, N.Y.-based healthcare equipment manufacturer will continue to trade on the OTCQX until the market closes Oct. 16.

Repro Med, which is doing business as RMS Medical Products, designs, manufactures and markets portable medical devices for administrating medication into a vein.